Researcher
Ghesquiere Bart
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology, (Bio)molecular modelling and design, Analytical biochemistry, Auto-ecology, Biogeography and phylogeography, Anthropological genetics, Bacteriology, Cell death and senescence, Epigenomics, Environmental safety and health of nanotechnology, Medical biophysics, General diagnostics, Adaptive immunology, Behavioural neuroscience
- Disciplines (KU Leuven):Metabolomics, Separation techniques, Spectrometry, Regulation of metabolism
- See also: Bart Ghesquière (KU Leuven)
Affiliations
- Metabolomics Expertise Center (VIB-KU Leuven) (Division)
Responsible
From1 Oct 2016 → Today - VIB Metabolomics Core Leuven (Core Lab)
Responsible
From1 Sep 2017 → Today - VIB-KU Leuven Center for Cancer Biology (Research Center)
Responsible
From1 Sep 2017 → Today - Ghesquière Lab (Research group)
Responsible
From1 Sep 2017 → Today - VIB Metabolomics Core Leuven (Core Lab)
Responsible
From1 Jan 2017 → Today - Metabolomics Expertise Center (VIB-KU Leuven) (Division)
Member
From1 Oct 2016 → 30 Sep 2022 - Laboratory of Angiogenesis and Vascular Metabolism (VIB-KU Leuven) (Division)
Member
From1 Jan 2012 → 30 Sep 2014
Projects
1 - 5 of 5
- Tracer Raman-Driven Mass Spectrometry Imaging (TRaMaSI): a new platform for on-tissue Tracing of Nutritional and Biochemical Trajectories.From1 May 2024 → TodayFunding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- VIB Grant for Ghesquière Lab_Period:2022-01-01-2026-12-31From1 Jan 2022 → TodayFunding: FRI - Project driven research
- BE19-COMMUNITYLED (Bestaat uit de projecten GALAXY en PLANTS en gedeelte voor BaGh)From1 Jun 2019 → 31 May 2021Funding: EMBL
- 'Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions’ — ‘COLOSSUS’From1 Jan 2018 → 31 Dec 2022Funding: Other EU initiatives out of framework
- VIB Grant for Ghesquière Lab_Period:2018-01-01-2021-12-31From1 Jan 2018 → 31 Dec 2021Funding: FRI - Project driven research
Publications
21 - 30 of 75
- Lipid droplet degradation by autophagy connects mitochondria metabolism to Prox1-driven expression of lymphatic genes and lymphangiogenesis.(2022)
Authors: Odeta Mece, Diede Houbaert, Maria Livia Sassano, Marco Schaaf, Sanket More, Melissa Garcia Caballero, Mila Borri, Jelle Verhoeven, Madhur Agrawal, Kathryn Jacobs, et al.
Pages: 2760 - TraVis Pies: A Guide for Stable Isotope Metabolomics Interpretation Using an Intuitive Visualization.(2022)
Authors: Karen Driesen, Bart Ghesquière
Pages: 593 - The sodium-glucose co-transporter-2 inhibitor ertugliflozin modifies the signature of cardiac substrate metabolism and reduces cardiac mTOR signalling, endoplasmic reticulum stress and apoptosis.(2022)
Authors: Bart Ghesquière
Pages: 2263-2272 - How tech-savvy employees make the difference in core facilities: Recognizing core facility expertise with dedicated career tracks: Recognizing core facility expertise with dedicated career tracks.(2022)
Authors: Saskia Lippens, Dominique Audenaert, Alexander Botzki, Stefaan Derveaux, Bart Ghesquière, Geert Goeminne, Gholamreza Hassanzadeh Ghassabeh, Jurgen Haustraete, Francis Impens, Sebastian Munck, et al.
Pages: e55094 - TRAPPC9-CDG: A novel congenital disorder of glycosylation with dysmorphic features and intellectual disability.(2022)
Authors: Silvia Radenkovic, Bart Ghesquière
Pages: 894-904 - Reprogramming of glucocorticoid receptor function by hypoxia.(2022)
Authors: Tineke Vanderhaeghen, Steven Timmermans, Jolien Vandewalle, Charlotte Wallaeys, Lise Van Wyngene, Kelly Van Looveren, Louise Nuyttens, Bart Ghesquière, Karolien De Bosscher, Rudi Beyaert, et al.
Pages: e53083 - Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction.(2022)
Authors: Matthew Bird, Bram Decru, Bart Ghesquière
Pages: 101537 - Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells.(2022)
Authors: Bart Ghesquière
Pages: 101410 - Human and mouse non-targeted metabolomics identify 1,5-anhydroglucitol as SGLT2-dependent glycemic marker.(2021)
Authors: Bart Ghesquière
Pages: e470 - A20 deficiency in myeloid cells protects mice from diet-induced obesity and insulin resistance due to increased fatty acid metabolism.(2021)
Authors: Leen Catrysse, Bastiaan Maes, Parul Mehrotra, Arne Martens, Esther Hoste, Christian Maueroder, Anneleen Remmerie, Anna Bujko, Karolina Lucja Slowicka, Bart Ghesquière, et al.
Pages: 109748
Patents
1 - 5 of 5
- METHODS FOR ANALYZING THE PERFUSATE OF AN EX SITU MACHINE PERFUSED KIDNEY (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)